On June 17, Bioservo AB and Skelex BV signed an agreement on the acquisition of rights for Ironhand. Through this agreement, Skelex takes over the rights to develop and sell Ironhand and expands its portfolio of exoskeletons for the industrial market. Bioservo will fully focus on the life science market and continue to develop and sell Carbonhand.
Through this partnership, Skelex is granted global exclusive distribution rights to the existing Ironhand product and a license to the Bioservo technology for developing, manufacturing, and selling new products based on the technology. Skelex also acquires the rights to the trademark Ironhand.
By the acquisition of Ironhand, Skelex not only adds the support for hand-intensive work tasks to their current product range for shoulder and back support, they also add on active exoskeleton technology into their offering.
“We are thrilled to announce Skelex’s recent acquisition of the Ironhand from Bioservo. This strategic addition to our product portfolio not only broadens our scope with a complimentary active exoskeleton but also lays the foundation for Skelex to venture into Bionics and unlock the next generation of performance-enhancing wearables. By integrating Ironhand’s pioneering soft exoskeleton technology, we are poised to launch a new, cutting-edge innovation roadmap that aligns with Skelex’s mission to improve safety and performance for industrial athletes globally,” says Gaurav Genani, CEO Skelex.
“Bioservo will be able to devote its commercial focus towards life science, which has been the company’s roots since the first glove based on its unique SEM technology was invented almost 20 years ago. After further refining and developing the technology and creating solutions for both patients and industrial workers, the company is now making a strategic choice to fully focus on helping people with impaired hand function regain independence and resume everyday activities. Bioservo’s Carbonhand product has been a success in Europe and has started to gain momentum in the US, the company is now focusing on further growth in these markets,” says Petter Bдckgren, CEO Bioservo.
This is also the starting point for a partnership between Bioservo and Skelex, where both companies’ long experience in developing unique solutions to empower people is leveraged to jointly further develop breakthrough technologies to be applied both for industrial applications and in the healthcare sector.
